Inhibitor incidence in an unselected cohort of previously untreated patients with severe haemophilia B: a PedNet study

Department of Paediatrics, Medical University of Vienna, Austria;
Centre for Thrombosis and Hemostasis, Skane University Hospital, Malmö, Sweden;
CRTH, Hopital Bicêtre, Kremlin, France;
Haemophilia Center, Dept of Haematology, Great Ormond Street Hospital for Children, London, UK;
Dr. V. Haunersches Kinderspital, University of Munich, Germany;
Van Creveld Kliniek, University Medical Center Utrecht, Utrecht, The Netherlands;
Haemophilia-Haemostasis Unit, St. Sophia Children Hospital, Athens, Greece;
Fondazione IRCCS Ca Granda, Ospedale Maggiore Policlinico, Milan, Italy;
APHM, La Timone Children Hospital, Center for Bleeding Disorders, Marseille, France;
Department of Paediatric Haematology, Children Health Ireland at Crumlin, Dublin, Ireland;
J.W. Goethe University Hospital, Department of Pediatrics, Frankfurt, Germany;
National Hemophilia Center, Ministry of Health, Sheba Medical Center, Tel Hashomer, Israel;
Department of Clinical Sciences, Department of Pediatrics, Lund University, Lund, Sweden;
PedNet Haemophilia Research Foundation, Baarn, The Netherlands
Haematologica Early view Jan 9, 2020